Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alexandra Duplaine"'
Autor:
Julia Holzgruber, Christina Martins, Zsofi Kulcsar, Alexandra Duplaine, Erik Rasbach, Laure Migayron, Praveen Singh, Edith Statham, Jennifer Landsberg, Katia Boniface, Julien Seneschal, Wolfram Hoetzenecker, Emma L. Berdan, Shannan Ho Sui, Matthew R. Ramsey, Steven R. Barthel, Tobias Schatton
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract Programmed cell death 1 (PD-1) is a premier cancer drug target for immune checkpoint blockade (ICB). Because PD-1 receptor inhibition activates tumor-specific T-cell immunity, research has predominantly focused on T-cell-PD-1 expression and
Externí odkaz:
https://doaj.org/article/209ec2809d724247864f9587c7cce533
Autor:
Alexandra Duplaine, Olivier Cogrel
Publikováno v:
Skin Appendage Disorders. 8:427-430
Introduction: Recent expert recommendations suggest mycophenolate mofetil (MMF) as a third-line therapy, in severe corticosteroid-dependent or corticosteroid-resistant nail lichen planus (NLP). However, there is currently no literature to support MMF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e03b6b3799d8f0327a96aa88d24ccb7d
https://doi.org/10.1159/000524246
https://doi.org/10.1159/000524246
Autor:
Alexandra Duplaine, Bernard Cribier, Jean-Philippe Arnault, Laurent Mortier, N. Poulalhon, Jean-Jacques Grob, Marie Beylot-Barry, Maxime Battistella, Thomas Jouary, Sandrine Mansard, Philippe Saiag, Hervé Maillard
Publikováno v:
Journal of the American Academy of Dermatology. 86:1365-1366
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09fb8cb992a332b93308004ff7574b6f
https://doi.org/10.1016/j.jaad.2021.05.024
https://doi.org/10.1016/j.jaad.2021.05.024
Autor:
Clélia Favary, Hervé Maillard, N. Andreu, Khaled Ezzedine, Thierry Passeron, Alexandra Duplaine, Catherine Droitcourt, Régis Lassalle, Julien Seneschal, Alain Taïeb
Publikováno v:
Journal of Investigative Dermatology
Journal of Investigative Dermatology, Nature Publishing Group, 2021, 141 (7), pp.1728-1734. ⟨10.1016/j.jid.2020.12.028⟩
Journal of Investigative Dermatology, Nature Publishing Group, 2021, 141 (7), pp.1728-1734. ⟨10.1016/j.jid.2020.12.028⟩
Background Topical calcineurin inhibitors are used off label in the treatment of vitiligo, and there is a lack of placebo-controlled, blinded studies to support their use. Objective This study aimed to compare the efficacy of tacrolimus 0.1% ointment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b0d86654fbcfae5c70268b89a015657
https://hal.archives-ouvertes.fr/hal-03700544
https://hal.archives-ouvertes.fr/hal-03700544
Autor:
Olivier Cogrel, Alexandra Duplaine
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A272-A273
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19bbb72c95c6e30b18b842d072e13f63
https://doi.org/10.1016/j.fander.2021.09.274
https://doi.org/10.1016/j.fander.2021.09.274
Autor:
Sorilla Prey, Gwendal Le-Masson, Caroline Dutriaux, Alexandra Duplaine, Camille Prot, Antoine Soulages, Fanny Duval
Publikováno v:
Neurological Sciences. 42:5377-5378
Introduction Myasthenia gravis (MG) Lambert-Eaton (LE) overlap syndrome is a rare condition. Here, we describe the first case of MG-LE overlap syndrome revealed by the anti-programmed cell death 1 inhibitor, nivolumab, in a patient treated for metast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f464b3ca1174047e5affabdac59bc794
https://doi.org/10.1007/s10072-021-05557-9
https://doi.org/10.1007/s10072-021-05557-9
Autor:
Khaled Ezzedine, Thierry Passeron, Nicolas Dupin, Olivier Chosidow, Alexandra Duplaine, Bernard Guillot, Marie Beylot-Barry, Julien Seneschal
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A260
Introduction La prise en charge des dermatoses est parfois limitee : developpement industriel de medicaments pour une indication donnee, ruptures de stock, maladies orphelines, retrait du marche. Le vitiligo est une dermatose frequente (0,5–2 %), a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f51303ac0d79323d7b2a2153dbc094c
https://doi.org/10.1016/j.fander.2021.09.248
https://doi.org/10.1016/j.fander.2021.09.248